Status:
COMPLETED
Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers
Lead Sponsor:
POZEN
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
Study to determine a single dose bioavailablity of PA32540 is similar to EC aspirin 325 mg with respect to salicylic acid.
Eligibility Criteria
Inclusion
- Standard for PK
- Ages 18-55 years old
- Males and females
Exclusion
- Standard for PK
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00632086
Start Date
February 1 2008
End Date
February 1 2008
Last Update
March 10 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.